Pharmaceuticals Market Research Reports & Industry Analysis

Pharmaceuticals refer to compounds manufactured for use as a medicinal drug. Companies active in the pharmaceutical industry are involved in development, production and marketing of pharmaceuticals.

The global market for pharmaceuticals is demonstrating a substantial growth in Latin America and Asia, but is relatively stable in Europe. The worldwide market is assessed at about USD 300 billion yearly. The USA, Japan, Germany, France and China are the top pharmaceutical markets. The pharmaceutical industry benefits from the ageing population; new medical discoveries and new drugs approvals; the increased number of chronic, degenerative and heart diseases, and cancer.

The research reports of this Catalogue cover all the major categories within global, regional and local pharmaceuticals markets. The reports offer overviews of the market trends, drivers; factors contributing to market growth. The challenges faced by industry participants, analyses of the top companies involved in the marketplace, and the key market news are provided in the reports.

Found 35085 publications
Global Myocardial Infarction Drugs Market Report 2018 US$ 2,350.00

... a relatively optimistic growth, the past four years, Myocardial Infarction Drugs market size to maintain the average annual growth rate of ... few years, Myocardial Infarction Drugs market size will be further expanded, we expect that by 2022, The market size of the Myocardial Infarction Drugs will reach XXXX ...

Feb, 2018 127 pages
Global Metabolism Drugs Market Report 2017 US$ 2,350.00

... maintained a relatively optimistic growth, the past four years, Metabolism Drugs market size to maintain the average annual growth rate of 5.68% ... next few years, Metabolism Drugs market size will be further expanded, we expect that by 2021 , The market size of the Metabolism Drugs will reach 16120 million ...

Feb, 2018 115 pages
Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase... US$ 3,500.00

... report also reviews key players involved in Tyrosine Protein Kinase Receptor TYRO3 (Tyrosine Protein Kinase BYK or Tyrosine Protein Kinase DTK or Tyrosine Protein Kinase RSE or Tyrosine Protein Kinase TIF or Tyrosine Protein Kinase SKY or TYRO3 or EC 2.7.10.1) targeted therapeutics development with respective ...

Jan, 2018 34 pages
Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygenase or CYP17 or CYP17A1 or EC... US$ 3,500.00

... It also reviews key players involved in Steroid 17 Alpha Hydroxylase/17,20 Lyase (17 Alpha Hydroxyprogesterone Aldolase or Cytochrome P450 17A1 or Cytochrome P450 C17 or Steroid 17 Alpha Monooxygenase or CYP17 or CYP17A1 or EC 1.14.14.19 or EC 4.1.2.30) targeted therapeutics development with respective active ...

Jan, 2018 69 pages
Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) - Pipeline Review, H1 2018 US$ 3,500.00

... Respiratory Syncytial Virus Attachment Glycoprotein (RSV G or G) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

Jan, 2018 40 pages
Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) -... US$ 3,500.00

... and molecule type. It also reviews key players involved in Protein Glutamine Gamma Glutamyltransferase 2 (Tissue Transglutaminase or Transglutaminase C or Transglutaminase H or Transglutaminase 2 or TGase C or TGase H or TGM2 or EC 2.3.2.13) targeted therapeutics development with respective active and dormant ...

Jan, 2018 32 pages
NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) - Pipeline Review, H1 2018 US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding NT 3 Growth Factor Receptor (TrkC Tyrosine Kinase or GP145 TrkC or Neurotrophic Tyrosine Kinase Receptor Type 3 or NTRK3 or EC 2.7.10.1) development landscape Develop and ...

Jan, 2018 62 pages
MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) - Pipeline Review, H1 2018 US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding MAP Kinase Interacting Serine/Threonine Protein Kinase 2 (MAP Kinase Signal Integrating Kinase 2 or MKNK2 or EC 2.7.11.1) development landscape Develop and design ...

Jan, 2018 39 pages
Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) - Pipeline Review, H1 2018 US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Macrophage Stimulating Protein Receptor (CDw136 or Protein Tyrosine Kinase 8 or p185 Ron or CD136 or MST1R or EC 2.7.10.1) development landscape Develop and design ...

Jan, 2018 51 pages
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) - Pipeline Review, H1 2018 US$ 3,500.00

... Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

Jan, 2018 47 pages
Galectin 1 (14 kDa Laminin Binding Protein or 14 kDa Lectin or Beta Galactoside Binding Lectin L 14 I or Galaptin or HBL or HPL or Lactose Binding Lectin 1 or Lectin Galactoside Binding... US$ 3,500.00

... Galectin 1 (14 kDa Laminin Binding Protein or 14 kDa Lectin or Beta Galactoside Binding Lectin L 14 I or Galaptin or HBL or HPL or Lactose Binding Lectin 1 or Lectin Galactoside Binding Soluble 1 or Putative MAPK Activating Protein PM12 or S Lac Lectin 1 or LGALS1) targeted therapeutics under development ...

Jan, 2018 62 pages
Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) - Pipeline Review, H1 2018 US$ 3,500.00

... Alpha Synuclein (Non A Beta Component Of AD Amyloid or Non A4 Component Of Amyloid Precursor or NACP or SNCA) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

Jan, 2018 101 pages
World Potential Analysis of Ebola drug and Vaccines Market - Opportunities and Forecasts, 2020 US$ 3,099.00

... regulations in order to curb the spread of this disease. Global Potential Analysis of Ebola drug and Vaccines Market KEY BENEFITS This report offers ... held in past years concerning the development of ebola viral disease therapeutics Pin-point analysis of geographic segments helps to identify opportunities ...

Sep, 2014 55 pages
Biosimilars Market (Follow-on-Biologics) by Types (Human growth hormone, Erythropoietin, Monoclonal antibodies, Insulin, Interferon, Granulocyte-Colony Stimulating Factor, Peptide) and... US$ 4,640.00

... impact of these restraints over the forecast period. Global biosimilars/follow-on-biologics market accounted for an overall revenue of $2,552.0 million ... Key Deliverables Global biosimilars/follow-on-biologics market is categorized into product types, applications and geography. MARKET BY TYPE S Human growth ...

Sep, 2015 120 pages
Potting Compounds Market by Resin Type (Epoxy, Polyurethane, Silicone, Polyester, Polyamide, Polyolefin and Acrylics), by Curing Technique (UV, Thermal and Room Temperature), by... US$ 4,099.00

... such as China and India. The report segments potting compounds market on the basis of resin type, curing technique, application, end-user, ... and emerging estimations & dynamics in the potting compounds market. In-depth analysis is conducted by potting compounds market estimations for key segments during the ...

Feb, 2017 450 pages
Gynecological Cancer Drugs Market by Therapeutic Modality (Chemotherapy, Targeted Therapy, and Hormonal Therapy) and Indication (Cervical Cancer, Uterine Cancer, Ovarian Cancer, and... US$ 4,640.00

... gynecological cancer drugs market size was valued at $9,269 million in 2016, and is expected to reach $16,107 million by 2023, growing at a CAGR of 8.1% from 2017 to 2023. Cancer ... the uterus. High incidence of gynecological cancers, rise in importance of targeted drug therapies, rise in investment from ...

Dec, 2017 188 pages
Immunoglobulin Market by Application (Hypogammaglobulinemia, Chronic Inflammatory Demyelinating Polyneuropathy, Immunodeficiency Diseases, Myasthenia Gravis, Multifocal Motor Neuropathy,... US$ 4,640.00

... report segments the global immunoglobulin market based on application, product type, mode of delivery, and concentration. Applications covered in the study include hypogammaglobulinemia, CIDP, immunodeficiency diseases ...

Jul, 2017 220 pages
Bio-alcohols Market by Type (Bioethanol, Biomethanol, Biobutanol, and BDO), by Application (Transportation, Power Generation, Medical, and Others), and Raw Material (Grains, Sugarcane,... US$ 4,099.00

... the growth of the global bio-alcohols market is provided. Extensive analysis of the bio-alcohols market is conducted by following key ... market. Bio-alcohols market share by type, application, and raw material at all geographic levels are defined in this report BIO-ALCOHOLS MARKET KEY SEGMENTS: By Type Bioethanol ...

Feb, 2017 166 pages
Potential Analysis of Human DNA Vaccines Market by Forecast Scenario Analysis (Rapid Growth Scenario, Moderate Growth Scenario, and Low Growth Scenario) - Global Opportunity Analysis and... US$ 4,099.00

... cost lower than conventional method of vaccines. The global potential analysis of DNA vaccines market is expected to account $3,762 million in ... . The global potential analysis of human DNA vaccine market is segmented based on forecast scenario analysis and region. Based on forecast scenario analysis, it is ...

Jun, 2017 120 pages
In Vitro Fertilization (IVF) Services Market by Cycle Type (Fresh, Thawed IVF and Donor Egg IVF Cycle) and End User (Fertility Clinics, Hospitals, Surgical Centres and Clinical Research... US$ 4,640.00

In vitro fertilization (IVF) is the process of artificial fertilization which happens outside the women’s body. The egg of the women is surgical removed and are fertilized by ... developing nations would offer lucrative growth opportunities for IVF service providers in future. Further, the growing clinical ...

Dec, 2017 568 pages
Oilfield Chemicals Market by Type (Biocides, Corrosion & Scale Inhibitors, Demulsifiers, Surfactants, Polymers, Gellants & Viscosifiers, and Others) and Application (Drilling Fluids,... US$ 4,099.00

... expected to hamper the market growth in the near future. The global oilfield chemicals market is segmented based on type, application, and geography ... . On the basis of type, it is divided as biocides, ...

May, 2017 170 pages
Gene Therapy Market by Vector Type (Viral Vector and Non-viral Vector), Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth Factors, Receptors, and Others), and... US$ 3,840.00

... for gene therapy and the high costs of gene therapy drugs are expected to hinder the growth of the market. The global gene therapy market is segmented based on vector type, gene type ...

Feb, 2018 232 pages
Vaccines Market by Technology (Conjugate Vaccines, Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, and Other Vaccines), Indication (Pneumococcal... US$ 4,640.00

... opportunities Key Market segment: Global vaccines market by, Types Attenuated vaccines Inactivated vaccines Conjugated vaccines Recombinant vaccines Subunit vaccine Combination vaccines Toxoid vaccines Global vaccines market by, Applications Therapeutic vaccines Prophylactic vaccines Based on diseases ...

May, 2017 240 pages
1 2 3 4 5 >
Skip to top